Annual CFI
$0.00
-$8.02 M-100.00%
March 31, 2023
Summary
- As of March 6, 2025, MDNA annual cash flow from investing activities is $0.00, with the most recent change of -$8.02 million (-100.00%) on March 31, 2023.
- During the last 3 years, MDNA annual CFI has risen by +$11.28 million (+100.00%).
Performance
MDNA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
N/A
June 30, 2023
Summary
- MDNA quarterly cash flow from investing activities is not available.
Performance
MDNA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
N/A
June 30, 2023
Summary
- MDNA TTM cash flow from investing activities is not available.
Performance
MDNA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
MDNA Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | - | - |
| 3 y3 years | +100.0% | - | - |
| 5 y5 years | +100.0% | - | - |
MDNA Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | ||||
| 5 y | 5-year | -100.0% | <-9999.0% | ||||
| alltime | all time | -100.0% | <-9999.0% |
Medicenna Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2022 | - | $0.00(0.0%) | $42.70 K(-99.5%) |
| Sep 2022 | - | $0.00(-100.0%) | $7.98 M(-0.4%) |
| Mar 2022 | $8.02 M(+111.2%) | $42.70 K(-99.5%) | $8.02 M(+1.1%) |
| Dec 2021 | - | $7.94 M(<-9900.0%) | $7.93 M(>+9900.0%) |
| Sep 2021 | - | -$800.00(-102.5%) | $72.90 K(-99.5%) |
| Jun 2021 | - | $32.60 K(-174.4%) | $14.65 M(+286.0%) |
| Mar 2021 | $3.79 M(-133.6%) | -$43.80 K(-151.6%) | $3.80 M(-151.9%) |
| Dec 2020 | - | $84.90 K(-99.4%) | -$7.31 M(-2.8%) |
| Sep 2020 | - | $14.57 M(-234.7%) | -$7.53 M(-65.9%) |
| Jun 2020 | - | -$10.82 M(-3.0%) | -$22.10 M(+95.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | -$11.28 M(+4076.3%) | -$11.15 M(+8557.9%) | -$11.28 M(+3946.0%) |
| Dec 2019 | - | -$128.80 K(<-9900.0%) | -$278.80 K(+97.5%) |
| Sep 2019 | - | $0.00(0.0%) | -$141.20 K(-47.7%) |
| Jun 2019 | - | $0.00(-100.0%) | -$270.10 K(0.0%) |
| Mar 2019 | -$270.10 K(+146.9%) | -$150.00 K(-1804.5%) | -$270.10 K(+158.5%) |
| Dec 2018 | - | $8800.00(-106.8%) | -$104.50 K(-56.1%) |
| Sep 2018 | - | -$128.90 K(-926.3%) | -$238.30 K(+117.8%) |
| Mar 2018 | -$109.40 K(-113.3%) | $15.60 K(-112.5%) | -$109.40 K(-12.5%) |
| Dec 2017 | - | -$125.00 K | -$125.00 K |
| Mar 2017 | $822.70 K(>+9900.0%) | - | - |
| Mar 2016 | $0.00 | - | - |
FAQ
- What is Medicenna Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Medicenna Therapeutics?
- What is Medicenna Therapeutics annual CFI year-on-year change?
- What is the all time high quarterly CFI for Medicenna Therapeutics?
- What is the all time high TTM CFI for Medicenna Therapeutics?
What is Medicenna Therapeutics annual cash flow from investing activities?
The current annual CFI of MDNA is $0.00
What is the all time high annual CFI for Medicenna Therapeutics?
Medicenna Therapeutics all-time high annual cash flow from investing activities is $8.02 M
What is Medicenna Therapeutics annual CFI year-on-year change?
Over the past year, MDNA annual cash flow from investing activities has changed by -$8.02 M (-100.00%)
What is the all time high quarterly CFI for Medicenna Therapeutics?
Medicenna Therapeutics all-time high quarterly cash flow from investing activities is $14.57 M
What is the all time high TTM CFI for Medicenna Therapeutics?
Medicenna Therapeutics all-time high TTM cash flow from investing activities is $14.65 M